Endoscopic ultrasound-guided radiofrequency ablation of low-grade insulinomas

#3682

Introduction: Insulinomas are rare pancreatic neuroendocrine neoplasms that may cause significant symptoms and substantially reduce quality of life. In resectable patients, the current treatment recommendation is surgery with either enucleation or resection of all or parts of the gland. This treatment may be associated with high morbidity and long convalescence. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a new and minimally invasive treatment for patients with insulinomas.

Aim(s): To describe preliminary results with EUS-RFA in insulinoma patients.

Materials and methods: Single center experience obtained in four insulinoma patients treated with EUS-RFA.

Conference:

Presenting Author: Andreassen M

Authors: Jansen C, Vilmann P, Brink L, Andreassen M, Knigge U,

Keywords: Insulinoma, Endoscopic ultrasound, RFA,